Utilization of Human Fibrinogen Concentrate During Proximal Aortic Reconstruction with Deep Hypothermic Circulatory Arrest

OBJECTIVE: Human fibrinogen concentrate (HFC) is approved by the Food and Drug Administration for use at 70 mg/kg to treat congenital afibrinogenemia. We sought to determine whether this dose of HFC increases fibrinogen levels in the setting of high-risk bleeding associated with aortic reconstructio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Thorac Cardiovasc Surg
Egile Nagusiak: Hanna, Jennifer M., Keenan, Jeffrey E., Wang, Hanghang, Andersen, Nicholas D., Gaca, Jeffrey G., Lombard, Frederick W., Welsby, Ian J., Hughes, G. Chad
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5429587/
https://ncbi.nlm.nih.gov/pubmed/26428473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2015.08.079
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak